Log in
Enquire now
Regentis Biomaterials

Regentis Biomaterials

Regentis Biomaterials is a company founded by Dror Seliktar.

OverviewStructured DataIssuesContributors

Contents

regentis.co.il
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Tissue engineering
Tissue engineering
Regenerative medicine
Regenerative medicine
Medicine
Medicine
Healthcare
Healthcare
Biotechnology
Biotechnology
Pharmaceutical industry
Pharmaceutical industry
Location
United States
United States
Israel
Israel
CEO
‌
Alastair J. Clemow
Founder
‌
Dror Seliktar
Legal Name
Regentis Biomaterials Ltd.
Number of Employees (Ranges)
11 – 500
Email Address
info@regentis.co.il
sales@regentis.co.il
service@regentis.co.il
Phone Number
+97246265502
+492513226660
Full Address
12 Ha’ilan Street Northern Industrial Zone, P.O.Box 260 Or-Akiva 3060000, Israel
Borkstrasse 10 48163 Muenster, Germany
Investors
SCP Vitalife Partners
SCP Vitalife Partners
Crossroads Fund
Crossroads Fund
‌
Medica Venture Partners
‌
Technion Investment Opportunities Fund
Fax Number
+972.4.6265504
Total Funding Amount (USD)
10,000,000
Latest Funding Round Date
May 14, 2012
Latest Funding Type
Series C
Series C
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Regentis Biomaterials

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.